Roundtable: Evolving Quality of Life Measurements to Reflect the Impact of CIA
Author Affiliations
Related papers:
Abstract P5-08-10: Safety and Tolerability of Paxman Scalp Cooling at Lower Temperatures to Improve Efficacy with Anthracycline Chemotherapy
ViewAssociation Between Use of a Scalp Cooling Device and Alopecia After Chemotherapy for Breast Cancer
ViewScalp Cooling in Preventing Persistent Chemotherapy-Induced Alopecia: A Randomized Controlled Trial
ViewAbstract
Purpose
Quality of life scales have historically successfully tracked patient experience, but are now not successfully measuring the details required to reflect the advances in side effect management. Accurate quality of life measurements are needed for the nuances of a patient’s experience.
Related papers
“Dear hair loss” – illness perceptions of female patients with chemotherapy-induced alopecia
Chemotherapy-induced alopecia (CIA) is one of the most common and distressing side effects of chemotherapy treatment. This study aims to assess the illness perceptions of…
(pre-)Clinical research to understand alopecia and improve cooling results
• Authors: international multi-disciplinary special interest group (SIG) on chemotherapy-induced alopecia (CIA) & scalp cooling • Pathobiology of CIA is still not fully understood1 •…
A Clinical and Biological Guide for Understanding Chemotherapy-Induced Alopecia and Its Prevention
Chemotherapy-induced alopecia (CIA) is the most visibly distressing side effect of commonly administered chemotherapeutic agents. Because psychological health has huge relevance to lifestyle, diet, and…
